前列腺癌是全世界男性第二常见的癌症,估计2018年报告的新病例为1276万例,占所有男性癌症病例的7.1%.
前列腺癌的死亡率也很高,2018年全球估计有37,005人死亡.
然而,死亡率因地区而异,西非是世界上前列腺癌死亡率第五高的地区,尼日利亚是该地区人口和经济规模最大的地区.
在尼日利亚, 前列腺癌是男性最常见和最致命的癌症,
这是北美死亡率的两倍多.
疾病的晚发现,筛查和检测的资源有限,以及病例的记录和报告减少导致尼日利亚的高死亡率.
在美国,前列腺癌是男性癌症死亡的第二大常见原因,每年约有40,000名男性死于这种疾病.
自1990年代初以来,前列腺癌死亡率一直在慢慢下降,但仍然是一个重要的健康问题.
总的来说,前列腺癌是一种致命的疾病, 特别是在医疗保健和筛查资源有限的地区.
然而,早期发现和治疗可以显著改善结果并降低死亡率.
PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html
RefinedWeb https://arxiv.org/abs/2306.01116
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
本网站仅用于教育和信息目的,不构成提供医疗建议或专业服务.
提供的信息不应用于诊断或治疗健康问题或疾病, 寻求个人医疗建议的人应咨询有执照的医生.
请注意 , 产生答案的神经网络在数字内容方面是特别不准确的 , 比如 , 诊断出特定疾病的人数 ⁇
如果您认为您可能有医疗紧急情况,请立即拨打911或前往最近的急诊室. 本网站或其使用不会产生医生和患者的关系. BioMedLib或其员工,或本网站的任何贡献者,都不会对本网站提供的信息或其使用做出任何明确或暗示的声明.
1998年的"数字千年版权法" (Digital Millennium Copyright Act) 17 U.S.C. § 512 (
如果您真诚地认为与我们的网站或服务有关的任何内容或材料侵犯了您的版权,您(或您的代理人)可以向我们发送通知,要求删除内容或材料,或阻止访问.
通知必须以书面形式通过电子邮件发送(请参阅"联系"部分以获取电子邮件地址).
DMCA 要求您的版权侵权通知包括以下信息: (1) 描述被指控侵权的受版权保护的作品; (2) 描述被指控侵权的内容和足够的信息,使我们能够找到内容; (3) 您的联系信息,包括您的地址,电话号码和电子邮件地址; (4) 声明您有诚信的信念,认为所投诉的方式的内容未经版权所有者或其代理人或任何法律的授权;
(5) 您签署的声明,以免作伪证,证明通知中的信息是准确的,并且您有权强制执行据称被侵犯的版权;
(6) 版权所有者或授权代表版权所有者行事的人员的实物或电子签名 ⁇
如果不包括上述所有信息,可能会导致投诉处理的延迟.
请向我们发送任何问题/建议的电子邮件.
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
BioMedLib使用自动化计算机(机器学习算法)来生成问答对.
我们从PubMed/Medline的 3500 万份生物医学出版物开始 , 还有 RefinedWeb的网页 ⁇
参见"参考资料"以及"免责声明".